{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:02:40Z","timestamp":1793638960691,"version":"4.5.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930016"],"award-info":[{"award-number":["81930016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-024-01215-0","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T09:02:17Z","timestamp":1726736537000},"page":"1296-1308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hepatocellular carcinoma-specific epigenetic checkpoints bidirectionally regulate the antitumor immunity of CD4\u2009+\u2009T cells"],"prefix":"10.1038","volume":"21","author":[{"given":"Shuai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaofeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-3007","authenticated-orcid":false,"given":"Xiaohui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6327-6034","authenticated-orcid":false,"given":"Limin","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1459-8261","authenticated-orcid":false,"given":"Shusen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-520X","authenticated-orcid":false,"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuyong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2761-2811","authenticated-orcid":false,"given":"Xiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"1215_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-021-00484-9","volume":"6","author":"X Xiang","year":"2021","unstructured":"Xiang X, Wang J, Lu D, Xu X. Targeting tumor-associated macrophages to synergize tumor immunotherapy. Signal Transduct Target Ther. 2021;6:75.","journal-title":"Signal Transduct Target Ther"},{"key":"1215_CR2","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0140-6736(23)00961-3","volume":"402","author":"S Qin","year":"2023","unstructured":"Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, et al. Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomized, open-label, international phase 3 study. Lancet. 2023;402:1133\u201346.","journal-title":"Lancet"},{"key":"1215_CR3","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","volume":"185","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu X, Wang Z, Chen X, Wang L, Lu Y, et al. The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes. Cell. 2022;185:4049\u201366.","journal-title":"Cell"},{"key":"1215_CR4","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.immuni.2022.04.016","volume":"55","author":"BW MacNabb","year":"2022","unstructured":"MacNabb BW, Tumuluru S, Chen X, Godfrey J, Kasal DN, Yu J, et al. Dendritic cells can prime anti-tumor CD8(+) T-cell responses through major histocompatibility complex cross-dressing. Immunity. 2022;55:982\u201397.","journal-title":"Immunity"},{"key":"1215_CR5","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/j.immuni.2021.08.026","volume":"54","author":"JM Schenkel","year":"2021","unstructured":"Schenkel JM, Herbst RH, Canner D, Li A, Hillman M, Shanahan SL, et al. Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T cells in tumor-draining lymph nodes. Immunity. 2021;54:2338\u201353.","journal-title":"Immunity"},{"key":"1215_CR6","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","volume":"49","author":"CS Garris","year":"2018","unstructured":"Garris CS, Arlauckas SP, Kohler RH, Trefny MP, Garren S, Piot C, et al. Successful anti-PD-1 cancer immunotherapy requires T-cell-dendritic cell crosstalk involving the cytokines IFN-\u03b3 and IL-12. Immunity. 2018;49:1148\u201361.","journal-title":"Immunity"},{"key":"1215_CR7","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","volume":"50","author":"MT Chow","year":"2019","unstructured":"Chow MT, Ozga AJ, Servis RL, Frederick DT, Lo JA, Fisher DE, et al. Intratumoral activity of the CXCR3 chemokine system is required for the efficacy of Anti-PD-1 therapy. Immunity. 2019;50:1498\u2013512.","journal-title":"Immunity"},{"key":"1215_CR8","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-020-2611-3","volume":"584","author":"ST Ferris","year":"2020","unstructured":"Ferris ST, Durai V, Wu R, Theisen DJ, Ward JP, Bern MD, et al. cDC1 prime and are licensed by CD4(+) T cells to induce antitumor immunity. Nature. 2020;584:624\u20139.","journal-title":"Nature"},{"key":"1215_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41423-024-01133-1","volume":"21","author":"X Lei","year":"2024","unstructured":"Lei X, de Groot DC, Welters MJP, de Wit T, Schrama E, van Eenennaam H, et al. CD4(+) T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors. Cell Mol Immunol. 2024;21:374\u201392.","journal-title":"Cell Mol Immunol"},{"key":"1215_CR10","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41586-023-06199-x","volume":"618","author":"B Kruse","year":"2023","unstructured":"Kruse B, Buzzai AC, Shridhar N, Braun AD, Gellert S, Knauth K, et al. CD4(+) T-cell-induced inflammatory cell death controls immune-evasive tumors. Nature. 2023;618:1033\u201340.","journal-title":"Nature"},{"key":"1215_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adi9517","volume":"9","author":"EG Bawden","year":"2024","unstructured":"Bawden EG, Wagner T, Schr\u00f6der J, Effern M, Hinze D, Newland L, et al. CD4(+) T-cell immunity against cutaneous melanoma encompasses multifaceted MHC II-dependent responses. Sci Immunol. 2024;9:eadi9517.","journal-title":"Sci Immunol"},{"key":"1215_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1136\/gutjnl-2015-310814","volume":"66","author":"M Garnelo","year":"2017","unstructured":"Garnelo M, Tan A, Her Z, Yeong J, Lim CJ, Chen J, et al. Interaction between tumor-infiltrating B cells and T cells controls the progression of hepatocellular carcinoma. Gut. 2017;66:342\u201351.","journal-title":"Gut"},{"key":"1215_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/s41591-023-02345-0","volume":"29","author":"A Magen","year":"2023","unstructured":"Magen A, Hamon P, Fiaschi N, Soong BY, Park MD, Mattiuz R, et al. Intratumoral dendritic cell-CD4(+) T helper cell niches enable CD8(+) T-cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nat Med. 2023;29:1389\u201399.","journal-title":"Nat Med"},{"key":"1215_CR14","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.immuni.2017.10.009","volume":"47","author":"T Ahrends","year":"2017","unstructured":"Ahrends T, Spanjaard A, Pilzecker B, B\u0105ba\u0142a N, Bovens A, Xiao Y, et al. CD4(+) T-cell help confers a cytotoxic T-cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity. 2017;47:848\u201361.","journal-title":"Immunity"},{"key":"1215_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cell.2020.11.041","volume":"184","author":"Y Sun","year":"2021","unstructured":"Sun Y, Wu L, Zhong Y, Zhou K, Hou Y, Wang Z, et al. Single-cell landscape of the ecosystem in early-relapse hepatocellular carcinoma. Cell. 2021;184:404\u201321.","journal-title":"Cell"},{"key":"1215_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216336","volume":"571","author":"S Wang","year":"2023","unstructured":"Wang S, Xu N, Wang J, Chen Y, Li W, Chen H, et al. BMI1-induced CD127+KLRG1+ memory T cells enhance the efficacy of liver cancer immunotherapy. Cancer Lett. 2023;571:216336.","journal-title":"Cancer Lett"},{"key":"1215_CR17","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccell.2022.06.001","volume":"40","author":"JA Belk","year":"2022","unstructured":"Belk JA, Yao W, Ly N, Freitas KA, Chen YT, Shi Q, et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell. 2022;40:768\u201386.","journal-title":"Cancer Cell"},{"key":"1215_CR18","doi-asserted-by":"publisher","first-page":"e143948","DOI":"10.1172\/jci.insight.143948","volume":"6","author":"AM Malik","year":"2021","unstructured":"Malik AM, Barmada SJ. Matrin 3 in neuromuscular disease: physiology and pathophysiology. JCI Insight. 2021;6:e143948.","journal-title":"JCI Insight"},{"key":"1215_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41422-023-00812-4","volume":"33","author":"Z Lin","year":"2023","unstructured":"Lin Z, Zhao S, Li X, Miao Z, Cao J, Chen Y, et al. Cathepsin B S-nitrosylation promotes ADAR1-mediated editing of its own mRNA transcript via an ADD1\/MATR3 regulatory axis. Cell Res. 2023;33:546\u201361.","journal-title":"Cell Res"},{"key":"1215_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18949-w","volume":"11","author":"CS Kao","year":"2020","unstructured":"Kao CS, van Bruggen R, Kim JR, Chen XXL, Chan C, Lee J, et al. Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS. Nat Commun. 2020;11:5304.","journal-title":"Nat Commun"},{"key":"1215_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103900","volume":"25","author":"ML Sprunger","year":"2022","unstructured":"Sprunger ML, Lee K, Sohn BS, Jackrel ME. Molecular determinants and modifiers of Matrin-3 toxicity, condensate dynamics, and droplet morphology. iScience. 2022;25:103900.","journal-title":"iScience"},{"key":"1215_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000200006","volume":"8","author":"A Manini","year":"2022","unstructured":"Manini A, Velardo D, Ciscato P, Cinnante C, Moggio M, Comi G, et al. Expanding the phenotypic spectrum of vocal cord and pharyngeal weakness with distal myopathy due to the p.S85C MATR3 mutation. Neurol Genet. 2022;8:e200006.","journal-title":"Neurol Genet"},{"key":"1215_CR23","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/s41556-021-00725-7","volume":"23","author":"RL McCarthy","year":"2021","unstructured":"McCarthy RL, Kaeding KE, Keller SH, Zhong Y, Xu L, Hsieh A, et al. Diverse heterochromatin-associated proteins repress distinct classes of genes and repetitive elements. Nat Cell Biol. 2021;23:905\u201314.","journal-title":"Nat Cell Biol"},{"key":"1215_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 2013;14:7.","journal-title":"BMC Bioinforma"},{"key":"1215_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol. 2019;37:773\u201382.","journal-title":"Nat Biotechnol"},{"key":"1215_CR26","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41587-020-0442-2","volume":"38","author":"A Giladi","year":"2020","unstructured":"Giladi A, Cohen M, Medaglia C, Baran Y, Li B, Zada M, et al. Dissecting cellular crosstalk by sequencing physically interacting cells. Nat Biotechnol. 2020;38:629\u201337.","journal-title":"Nat Biotechnol"},{"key":"1215_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07153-z","volume":"12","author":"Y Jin","year":"2022","unstructured":"Jin Y, An X, Mao B, Sun R, Kumari R, Chen X, et al. Different syngeneic tumors show distinctive intrinsic tumor-immunity and mechanisms of actions (MOA) of anti-PD-1 treatment. Sci Rep. 2022;12:3278.","journal-title":"Sci Rep"},{"key":"1215_CR28","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/j.immuni.2022.06.006","volume":"55","author":"T Lan\u00e7a","year":"2022","unstructured":"Lan\u00e7a T, Ungerb\u00e4ck J, Da Silva C, Joeris T, Ahmadi F, Vandamme J, et al. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage. Immunity. 2022;55:1431\u201347.","journal-title":"Immunity"},{"key":"1215_CR29","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","volume":"56","author":"MA Moreno Ayala","year":"2023","unstructured":"Moreno Ayala MA, Campbell TF, Zhang C, Dahan N, Bockman A, Prakash V, et al. CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8(+) T cell antitumor immunity. Immunity. 2023;56:1613\u201330.","journal-title":"Immunity"},{"key":"1215_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31941-w","volume":"13","author":"R Saddawi-Konefka","year":"2022","unstructured":"Saddawi-Konefka R, O\u2019Farrell A, Faraji F, Clubb L, Allevato MM, Jensen SM, et al. Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC. Nat Commun. 2022;13:4298.","journal-title":"Nat Commun"},{"key":"1215_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05322-1","volume":"9","author":"F Bonacina","year":"2018","unstructured":"Bonacina F, Coe D, Wang G, Longhi MP, Baragetti A, Moregola A, et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T-cell activation. Nat Commun. 2018;9:3083.","journal-title":"Nat Commun"},{"key":"1215_CR32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1053\/j.gastro.2020.01.028","volume":"158","author":"WH Qin","year":"2020","unstructured":"Qin WH, Yang ZS, Li M, Chen Y, Zhao XF, Qin YY, et al. High serum levels of cholesterol increase antitumor functions of nature killer cells and reduce growth of liver tumors in mice. Gastroenterology. 2020;158:1713\u201327.","journal-title":"Gastroenterology"},{"key":"1215_CR33","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.cell.2018.11.044","volume":"176","author":"J Henriksson","year":"2019","unstructured":"Henriksson J, Chen X, Gomes T, Ullah U, Meyer KB, Miragaia R, et al. Genome-wide CRISPR screens in T helper cells reveal pervasive crosstalk between activation and differentiation. Cell. 2019;176:882\u201396.","journal-title":"Cell"},{"key":"1215_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41587-021-01033-z","volume":"40","author":"E Dann","year":"2022","unstructured":"Dann E, Henderson NC, Teichmann SA, Morgan MD, Marioni JC. Differential abundance testing on single-cell data using k-nearest neighbor graphs. Nat Biotechnol. 2022;40:245\u201353.","journal-title":"Nat Biotechnol"},{"key":"1215_CR35","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1111\/febs.14782","volume":"286","author":"MA Ajalla Aleixo","year":"2019","unstructured":"Ajalla Aleixo MA, Rangel VL, Rustiguel JK, de P\u00e1dua RAP, Nonato MC. Structural, biochemical and biophysical characterization of recombinant human fumarate hydratase. Febs J. 2019;286:1925\u201340.","journal-title":"Febs J"},{"key":"1215_CR36","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/s41586-019-1311-3","volume":"571","author":"W Bailis","year":"2019","unstructured":"Bailis W, Shyer JA, Zhao J, Canaveras JCG, Al Khazal FJ, Qu R, et al. Distinct modes of mitochondrial metabolism uncouple T-cell differentiation and function. Nature. 2019;571:403\u20137.","journal-title":"Nature"},{"key":"1215_CR37","doi-asserted-by":"publisher","first-page":"e20191453","DOI":"10.1084\/jem.20191453","volume":"217","author":"RE Tay","year":"2020","unstructured":"Tay RE, Olawoyin O, Cejas P, Xie Y, Meyer CA, Ito Y, et al. Hdac3 is an epigenetic inhibitor of the cytotoxicity program in CD8 T cells. J Exp Med. 2020;217:e20191453.","journal-title":"J Exp Med"},{"key":"1215_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41586-019-1805-z","volume":"576","author":"RC Lynn","year":"2019","unstructured":"Lynn RC, Weber EW, Sotillo E, Gennert D, Xu P, Good Z, et al. c-Jun overexpression in CAR T cells induces exhaustion resistance. Nature. 2019;576:293\u2013300.","journal-title":"Nature"},{"key":"1215_CR39","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41586-022-04849-0","volume":"607","author":"A Guo","year":"2022","unstructured":"Guo A, Huang H, Zhu Z, Chen MJ, Shi H, Yuan S, et al. cBAF complex components and MYC cooperate early in CD8(+) T-cell fate. Nature. 2022;607:135\u201341.","journal-title":"Nature"},{"key":"1215_CR40","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1158\/2326-6066.CIR-18-0466","volume":"7","author":"D Alizadeh","year":"2019","unstructured":"Alizadeh D, Wong RA, Yang X, Wang D, Pecoraro JR, Kuo CF, et al. IL15 enhances CAR-T-cell antitumor activity by reducing mTORC1 activity and preserving their stem cell memory phenotype. Cancer Immunol Res. 2019;7:759\u201372.","journal-title":"Cancer Immunol Res"},{"key":"1215_CR41","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","volume":"179","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, He Y, Luo N, Patel SJ, Han Y, Gao R, et al. Landscape and dynamics of single immune cells in hepatocellular carcinoma. Cell. 2019;179:829\u201345.","journal-title":"Cell"},{"key":"1215_CR42","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng C, Zheng L, Yoo JK, Guo H, Zhang Y, Guo X, et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell. 2017;169:1342\u201356.","journal-title":"Cell"},{"key":"1215_CR43","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1126\/science.aaz9761","volume":"367","author":"S He","year":"2020","unstructured":"He S, Wu Z, Tian Y, Yu Z, Yu J, Wang X, et al. Structure of nucleosome-bound human BAF complex. Science. 2020;367:875\u201381.","journal-title":"Science"},{"key":"1215_CR44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41596-020-0312-x","volume":"15","author":"Y Yan","year":"2020","unstructured":"Yan Y, Tao H, He J, Huang SY. The HDOCK server for integrated protein\u2012protein docking. Nat Protoc. 2020;15:1829\u201352.","journal-title":"Nat Protoc"},{"key":"1215_CR45","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s43018-022-00338-5","volume":"3","author":"M Cohen","year":"2022","unstructured":"Cohen M, Giladi A, Barboy O, Hamon P, Li B, Zada M, et al. The interaction of CD4(+) helper T cells with dendritic cells shapes the tumor microenvironment and immune checkpoint blockade response. Nat Cancer. 2022;3:303\u201317.","journal-title":"Nat Cancer"},{"key":"1215_CR46","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s43018-022-00506-7","volume":"4","author":"DK Lester","year":"2023","unstructured":"Lester DK, Burton C, Gardner A, Innamarato P, Kodumudi K, Liu Q, et al. Fucosylation of HLA-DRB1 regulates CD4(+) T-cell-mediated anti-melanoma immunity and enhances immunotherapy efficacy. Nat Cancer. 2023;4:222\u201339.","journal-title":"Nat Cancer"},{"key":"1215_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14642-0","volume":"11","author":"K Aslan","year":"2020","unstructured":"Aslan K, Turco V, Blobner J, Sonner JK, Liuzzi AR, N\u00fa\u00f1ez NG, et al. Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas. Nat Commun. 2020;11:931.","journal-title":"Nat Commun"},{"key":"1215_CR48","doi-asserted-by":"publisher","first-page":"e142513","DOI":"10.1172\/jci.insight.142513","volume":"6","author":"CC Balan\u00e7a","year":"2021","unstructured":"Balan\u00e7a CC, Salvioni A, Scarlata CM, Michelas M, Martinez-Gomez C, Gomez-Roca C, et al. PD-1 blockade restores helper activity of tumor-infiltrating, exhausted PD-1hiCD39+ CD4 T cells. JCI Insight. 2021;6:e142513.","journal-title":"JCI Insight"},{"key":"1215_CR49","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.immuni.2023.03.017","volume":"56","author":"S Quon","year":"2023","unstructured":"Quon S, Yu B, Russ BE, Tsyganov K, Nguyen H, Toma C, et al. DNA architectural protein CTCF facilitates subset-specific chromatin interactions to limit the formation of memory CD8(+) T cells. Immunity. 2023;56:959\u201378.","journal-title":"Immunity"},{"key":"1215_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42647-y","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Lee DS, Liang Y, Zheng Y, Dixon JR. Foxp3 orchestrates reorganization of chromatin architecture to establish regulatory T-cell identity. Nat Commun. 2023;14:6943.","journal-title":"Nat Commun"},{"key":"1215_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.it.2014.03.001","volume":"35","author":"EV Rothenberg","year":"2014","unstructured":"Rothenberg EV. The chromatin landscape and transcription factors in T-cell programming. Trends Immunol. 2014;35:195\u2013204.","journal-title":"Trends Immunol"},{"key":"1215_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.103825","volume":"76","author":"RR Jadhav","year":"2022","unstructured":"Jadhav RR, Hu B, Ye Z, Sheth K, Li X, Greenleaf WJ, et al. Reduced chromatin accessibility to CD4 T-cell superenhancers encompassing susceptibility loci of rheumatoid arthritis. EBioMedicine. 2022;76:103825.","journal-title":"EBioMedicine"},{"key":"1215_CR53","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202357550","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cao X, Gao Z, Ma X, Wang Q, Xu X, et al. MATR3-antisense LINE1 RNA meshwork scaffolds higher-order chromatin organization. EMBO Rep. 2023;24:e57550.","journal-title":"EMBO Rep"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01215-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01215-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01215-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T11:04:09Z","timestamp":1730372649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01215-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1038\/s41423-024-01215-0","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]},"assertion":[{"value":"20 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}